DNA Link, Inc., a genome-based biotechnology company, focuses on the research and development of genome analysis services in South Korea and internationally. Its next generation sequencing services include whole genome sequencing, De Novo sequencing, whole exome/targeted sequencing, transcriptome sequencing, epigenome sequencing, and single-cell RNA sequencing. The company also provides microarray services, such as DNA and microarray RNA analysis; Fluidigm BioMark System, an automated PCR/qPCR system; TaqMan assay; and SNaPshot assay. In addition, it offers Covid-19 diagnostic kits; DNAGPS, a personal genomics (PGX) solution; and AccuID, a personal identification microarray system. DNA Link, Inc. was founded in 2000 and is headquartered in Seoul, South Korea.